End Cash: The amount of cash held by the company for the given period.
Gossamer Bio, Inc. (GOSS) had End Cash of $41.15M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$9.24M |
|
$16.90M |
|
-- |
|
$9.24M |
|
$35.31M |
|
$-26.07M |
|
$42.97M |
|
$16.90M |
|
$16.90M |
|
$16.90M |
|
$16.90M |
|
$16.90M |
|
$16.90M |
|
$-26.07M |
|
$-21.26M |
|
320.01M |
|
328.78M |
|
$0.05 |
|
$0.08 |
|
| Balance Sheet Financials | |
$72.72M |
|
$0.06M |
|
$4.14M |
|
$76.87M |
|
$137.78M |
|
-- |
|
$33.11M |
|
$170.90M |
|
$-94.03M |
|
$-94.03M |
|
$-94.03M |
|
488.85M |
|
| Cash Flow Statement Financials | |
$-78.14M |
|
$84.31M |
|
$-2.63M |
|
$37.73M |
|
|
End Cash |
$41.15M |
$3.42M |
|
$8.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.53 |
|
-- |
|
-- |
|
-- |
|
-0.38 |
|
100.00% |
|
-282.25% |
|
-282.25% |
|
-- |
|
182.94% |
|
182.94% |
|
$-78.14M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
1.51 |
|
59.48 |
|
-17.97% |
|
-17.97% |
|
21.99% |
|
-17.97% |
|
$-0.19 |
|
$-0.24 |
|
$-0.24 |
|